Earnings History Data for Aurinia Pharmaceuticals Inc (AUPH) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc. is a late stage biopharmaceutical company. It focuses on the development of therapeutic immunomodulating drug candidate. The company's lead drug includes Voclosporin for the treatment of lupus nephritis. Aurinia Pharmaceuticals Inc. is headquartered in Victoria, Canada.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
10-05-2022 PM 6:00 AM ET
(May 10)
AUPH Aurinia Pharmaceuticals Inc 1,440 -0.27 -0.26 -0.40 Aurinia Pharma GAAP EPS of -$0.27 in-line, revenue of $21.63M beats by $2.39M
[5/10/2022 6:02 AM]
11.23 2.28 
(25.54%)
9.61 0.66 
(7.43%)
8.86 - 33.97 4,401,304 2,910,233 103,119
28-02-2022 PM 6:00 AM ET
(Feb 28)
AUPH Aurinia Pharmaceuticals Inc 2,070 -0.25 -0.26 -0.05 Aurinia Pharma GAAP EPS of -$0.25 beats by $0.02, revenue of $23.4M beats by $1.57M
[2/28/2022 6:00 AM]
12.39 -3.85 
(-23.71%)
11.68 -4.56 
(-28.08%)
9.72 - 33.97 19,407,009 2,910,000 1,904,004
03-11-2021 PM 8:00 AM ET
(Nov 3)
AUPH Aurinia Pharmaceuticals Inc 4,190 -0.39 -0.31 -0.28 Aurinia Pharma EPS misses by $0.06, beats on revenue
[11/3/2021 6:11 AM]
30.26 -1.74 
(-5.44%)
30.20 -1.80 
(-5.62%)
9.72 - 33.97 7,356,537 7,310,000 467,649
05-08-2021 AH 4:05 PM ET
(Aug 5)
AUPH Aurinia Pharmaceuticals Inc 1,740 -0.37 -0.35 -0.26 Aurinia Pharma EPS misses by $0.01, beats on revenue
[8/5/2021 4:16 PM]
14.36 2.65 
(22.63%)
13.16 1.45 
(12.38%)
9.72 - 20.50 11,151,253 5,580,000 122,800
06-05-2021 AH 4:00 PM ET
(May 6)
AUPH Aurinia Pharmaceuticals Inc 1,610 -0.40 -0.35 -0.15 Aurinia Pharma EPS misses by $0.02, misses on revenue
[5/6/2021 4:07 PM]
10.12 -2.21 
(-17.95%)
10.67 -1.67 
(-13.53%)
10.03 - 20.50 13,157,043 5,010,000 1,022,448
24-02-2021 AH 4:00 PM ET
(Feb 24)
AUPH Aurinia Pharmaceuticals Inc 2,020 -0.05 -0.31 -0.29 Aurinia Pharma EPS beats by $0.15, beats on revenue
[2/24/2021 4:07 PM]
14.60 0.02 
(0.14%)
15.00 0.42 
(2.88%)
9.83 - 20.50 6,039,395 3,110,710 298,675
10-11-2020 AH AUPH Aurinia Pharmaceuticals Inc 1,741 -0.28 -0.22 0.00 Aurinia Pharma EPS misses by $0.05, misses on revenue
[11/10/2020 4:29 PM]
13.25 -0.32 
(-2.36%)
13.77 0.20 
(1.47%)
4.90 - 21.93 1,810,047 1,646,203 6,849
11-08-2020 AH 4:00 PM ET
(Aug 11)
AUPH Aurinia Pharmaceuticals Inc 1,850 -0.26 -0.23 -0.17 Aurinia Pharma EPS misses by $0.03, revenue in-line
[8/11/2020 4:04 PM]
14.17 0.17 
(1.21%)
13.63 -0.37 
(-2.64%)
3.52 - 21.93 930,108 1,564,751 89,324
14-05-2020 AH 4:00 PM ET
(May 14)
AUPH Aurinia Pharmaceuticals Inc 2,000 -0.15 -0.20 -0.16 Aurinia Pharma EPS beats by $0.12, misses on revenue
[5/14/2020 4:07 PM]
17.16 -0.24 
(-1.38%)
17.13 -0.03 
(-0.17%)
3.52 - 21.93 1,311,086 1,093,498 9,045